Page last updated: 2024-10-23

bupivacaine and Carcinoma, Bronchogenic

bupivacaine has been researched along with Carcinoma, Bronchogenic in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cremonte, LG1
Mantellini, E1

Other Studies

1 other study available for bupivacaine and Carcinoma, Bronchogenic

ArticleYear
[Morphine combined with marcaine in long-term epidural analgesia in patients with Pancoast's syndrome caused by bronchogenic carcinoma of the apex of the lung].
    Minerva medica, 1989, Volume: 80, Issue:9

    Topics: Aged; Analgesia, Epidural; Bupivacaine; Carcinoma, Bronchogenic; Evaluation Studies as Topic; Female

1989